A new national effort to address stark inequalities in cardiovascular disease (CVD) outcomes is underway, backed by a £50 million investment from the National Institute for Health and Care Research (NIHR). Scientists at the University of Nottingham are playing a key role in the initiative, joining a consortium that aims to improve detection and management of heart conditions in underserved communities across the UK. This collaborative project, formally known as the NIHR Cardiovascular Disease Inequalities Challenge Consortium, recognizes that even as CVD remains a leading cause of death – contributing to 26% of all deaths in the UK, or more than 170,000 annually – its impact is not felt equally.
The consortium brings together a diverse group of institutions, including King’s College London, Lambeth Council, and Boots, alongside the University of Nottingham. The focus will be on tackling disparities experienced by ethnic minority communities and individuals living in deprived areas, as well as addressing differences in outcomes between men, and women. The partnership with the British Heart Foundation further strengthens the consortium’s capacity to drive meaningful change in cardiovascular health.
Addressing Systemic Barriers to Care
Professor Nadeem Qureshi, Clinical Professor in the University of Nottingham’s School of Medicine, emphasized the need for innovative approaches. “Primary care has long delivered established cardiovascular checks, but we know these services still don’t reach everyone who needs them most,” he said. “This consortium gives us the chance to develop more sustainable, community-grounded approaches that extend beyond traditional models of care. By working with local partners to design solutions that reflect real-world needs and overcome barriers to access, we can create long-lasting improvements in early detection of high blood pressure and raised cholesterol for underserved populations.”
The consortium’s strategy centers on testing innovative, community-based interventions. A key component will be leveraging the clinical and public health expertise within community pharmacies to transform how cardiovascular risk is identified and managed. The goal is to deliver earlier intervention and better health outcomes for patients who have historically been excluded from effective care. This approach acknowledges that traditional healthcare models often fail to adequately address the social determinants of health that contribute to disparities in CVD.
A Multi-University Approach to Research and Innovation
The University of Nottingham is one of several leading universities participating in the consortium. Others include the University of Glasgow, the University of Leeds, the University of Surrey, Swansea University, the University of Birmingham, the University of Ulster, Imperial College London, and the University of Bristol. Each institution will collaborate with a network of organizations – charities, social enterprises, local councils, NHS Trusts, and industry partners – to ensure that the consortium’s efforts lead to system-wide change.
Beyond improving detection and monitoring of hypertension and hypercholesterolemia, the consortium will prioritize building research capacity in the field. A core element of the initiative is a program of career development opportunities designed to inspire, develop, and support the next generation of researchers dedicated to addressing cardiovascular health inequalities. The research projects themselves are slated to commence in autumn 2026, with a focus on forging relationships with relevant charities, the life sciences industry, and patient groups.
Leveraging Technology and Public Health Messaging
The consortium plans to utilize a range of research activities to achieve its objectives, including the integration of wearable technologies and other digital health tools. Innovative public health messaging and education campaigns will also be central to the effort, with a particular emphasis on supporting sustained behavior change. These strategies reflect a recognition that addressing health inequalities requires a multifaceted approach that extends beyond clinical interventions.
Professor Lucy Chappell, Chief Scientific Adviser at the Department of Health and Social Care (DHSC) and Chief Executive Officer of the NIHR, highlighted the significance of this investment. “Cardiovascular disease causes 170,000 deaths annually in the UK, with a large long-term disease burden on the NHS. But it can be preventable with the right early intervention,” she stated. “This investment from the NIHR is one of the most ambitious attempts to tackle the root cause of inequalities of one the biggest killers.” She also noted that the NIHR is celebrating its 20th year of driving “life-changing research that matters.”
Reaching Diverse Communities Across the UK
The consortium’s geographic reach is intentionally broad, with member universities strategically located across the UK. This ensures that the initiative’s benefits will extend to diverse populations, including those in rural areas, coastal communities, and urban centers with high levels of deprivation. This commitment to inclusivity underscores the consortium’s dedication to addressing health inequalities on a national scale.
The consortium’s work is particularly timely, given growing awareness of the social factors that influence health outcomes. Recent research, for example, has shown a link between social deprivation and gut bacteria composition, potentially impacting cardiovascular health. Researchers at the University of Nottingham and King’s College London have been investigating this connection, highlighting the complex interplay between social and biological factors in cardiovascular disease.
The next key milestone for the consortium will be the launch of the research projects in autumn 2026. As the initiative progresses, stakeholders will be closely monitoring the development and implementation of new interventions, as well as the impact on cardiovascular health outcomes in underserved communities. The consortium’s success will depend on continued collaboration, innovation, and a steadfast commitment to addressing the root causes of health inequalities.
Disclaimer: This article provides information about a research initiative and should not be considered medical advice. Individuals with concerns about their cardiovascular health should consult with a qualified healthcare professional.
What are your thoughts on this new initiative? Share your comments below, and please share this article with your network to raise awareness about cardiovascular health inequalities.
